Nidek Co. LTD.
14
0
0
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
29%
4 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Clinical Study for TONOREF III Tested to ANSI Z80.10-2014
Role: lead
Comparative Study of the NIDEK TONOREF III with Predicate Devices
Role: lead
Agreement and Precision Study of the Nidek Mirante
Role: lead
Comparative Study of the NIDEK TONOREF III and the Haag-Streit Goldmann Manual Tonometer and Comparison of Pachymetry Values for NIDEK TONOREF III With the NIDEK CEM-530
Role: lead
Evaluation of the Rotational Stability
Role: lead
Comparative Study of Specular Microscopes for Measurements of Cell Density, Coefficient of Variation and Hexagonality
Role: lead
Clinical Evaluation of Toric Intraocular Lens
Role: lead
OCT Agreement and Crossed Precision Study
Role: lead
RS-3000 Lite Agreement Study
Role: lead
Data Collection Study of the Nidek Optical Coherence Tomography RS-3000 for 3D Measurements of the Eye
Role: lead
Prospective Comparative Clinical Study to Investigate the Use of the NON CONTACT TONO/PACHYMETER NT-530P
Role: lead
Comparative Study of the Optical Biometer for Measurements of the Eye
Role: lead
Comparative Study of Specular Microscope for Cell Density, Coefficient of Variation, Hexagonality and Corneal Thickness
Role: lead
Nidek RS3000 Comparative Study
Role: lead
All 14 trials loaded